SeaStar Medical (NASDAQ:ICU) & CochLear (OTCMKTS:CHEOY) Head-To-Head Review

CochLear (OTCMKTS:CHEOY) and SeaStar Medical (NASDAQ:ICU) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, analyst recommendations and institutional ownership.

Insider & Institutional Ownership

1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Valuation and Earnings

This table compares CochLear and SeaStar Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CochLear	$1.53 billion	3.60	$251.85 million	N/A	N/A
SeaStar Medical	$1.23 million	13.01	-$12.15 million	($4.80)	-0.83

CochLear has higher revenue and earnings than SeaStar Medical.

Volatility and Risk

CochLear has a beta of 0.69, indicating that its stock price is 31% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for CochLear and SeaStar Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CochLear	0	4	0	1	2.40
SeaStar Medical	1	0	1	0	2.00

CochLear currently has a consensus target price of $117.00, suggesting a potential upside of 178.90%. SeaStar Medical has a consensus target price of $8.00, suggesting a potential upside of 100.00%. Given CochLear’s stronger consensus rating and higher probable upside, research analysts clearly believe CochLear is more favorable than SeaStar Medical.

Profitability

This table compares CochLear and SeaStar Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CochLear	N/A	N/A	N/A
SeaStar Medical	-828.62%	-146.29%	-96.48%

Summary

CochLear beats SeaStar Medical on 9 of the 13 factors compared between the two stocks.

About CochLear

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.